Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2025-12-25 @ 7:18 PM
Study NCT ID:
NCT01890759
Status:
COMPLETED
Last Update Posted:
2022-04-19
First Post:
2013-06-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation
Sponsor:
Sanofi Pasteur, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-06-25
Start Date Type:
ACTUAL
Primary Completion Date:
2016-04-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-04-12
Completion Date Type:
ACTUAL
First Submit Date:
2013-06-27
First Submit QC Date:
None
Study First Post Date:
2013-07-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-07-18
Results First Submit QC Date:
None
Results First Post Date:
2017-08-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-24
Last Update Post Date:
2022-04-19
Last Update Post Date Type:
ACTUAL